Clinical Trial Update: Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating an extended-release liquid formulation of methylphenidate in adults with ADHD and autism spectrum disorder; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder

Drugs mentioned

• Methylphenidate ER liquid formulation (methylphenidate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Attention-deficit/Hyperactivity Disorder, Autism Spectrum Disorder | Phase 4 | Status: COMPLETED | Results posted: 2018-02-23